Another study reported that the inhibition of the interaction between p53 and MDM4, a negative regulator of p53, restores the activity of p53 in melanoma cells, resulting in an increased sensitivity to cytostatic or cytotoxic therapy [104]. Here, TP53 is linked to melanoma.